Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
Public ClinicalTrials.gov record NCT00823368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biomarker Testing and DNA Collection in Subjects Participating in a Double-Blind, Placebo-Controlled, Crossover, Flexible-Dose Evaluation of the Efficacy, Safety, and Tolerability of STX209 in the Treatment of Irritability in Subjects With Fragile X Syndrome
Study identification
- NCT ID
- NCT00823368
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Seaside Therapeutics, Inc.
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- STX209 Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Feb 28, 2010
- Completion
- Not listed
- Last update posted
- Jul 30, 2013
Started 2009
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Autism Research & Resource Center | Phoenix | Arizona | 85006 | — |
| University of California-Los Angeles Neuropsychiatric Institute | Los Angeles | California | 90024 | — |
| M.I.N.D. Institute | Sacramento | California | 95817 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Riley Hospital for Children | Indianapolis | Indiana | 46202 | — |
| NYS Institute for Basic Research in Developmental Disabilities | Staten Island | New York | 10314 | — |
| University of North Carolina Neurosciences Hospital | Chapel Hill | North Carolina | 27514 | — |
| Suburban Research Associates | Media | Pennsylvania | 19063 | — |
| Vanderbilt Kennedy Center | Nashville | Tennessee | 37203 | — |
| Red Oaks Psychiatry Associates, PA | Houston | Texas | 77090 | — |
| Seattle Children's Hospital | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00823368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2013 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00823368 live on ClinicalTrials.gov.